Humana stock just swung 20 points in a single day after CMS boosted its Medicare Advantage star ratings — a huge win on paper. But with a billion-dollar loss earlier this year, a lawsuit against the government, and fresh premium cuts squeezing margins, the big question is: is this a turnaround or just a temporary bounce? In this episode of Implied, we dig into Humana’s risky balancing act and what’s really at stake for investors.